GMP

Intravacc Announces the Publication of a GMP Process for a Semi-Synthetic Shigella Glycoconjugate Vaccine Candidate from Institut Pasteur

Intravacc

Alzheimer's Vaccine

Araclon Biotech Advances in Its Innovative Vaccine and Diagnostic Test for Alzheimer's

Araclon Biotech

License Agreement

Confirmation That the License to Develop Oral Vaccine Delivery Platform Has Been Executed

Poolbeg Pharma PLC

Vaccine

Vaxxas Announces $22 Million Award from U.S. Government to Advance Vaxxas Needle-Free HD-MAP™ Vaccine Patch Technology for Pandemic Response

Vaxxas

Moderna and Samsung Biologics Announce Agreement for Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine

Samsung Biologics

Partnership

DNA Script Partners with Moderna to Develop On-Demand Vaccines and Therapeutics for DARPA

DNA Script

Manufacturing

Sanofi to Invest in Vaccine Production Site in Singapore

Sanofi

Vaccine

Valneva Reports Positive Phase 1/2 Data for Its Inactivated, Adjuvanted COVID-19 Vaccine Candidate, VLA2001

Valneva SE

COVID-19 Vaccine

UBC Announces Initiative to Accelerate COVID-19 Vaccine Real-World Evidence Generation

UBC

COVID-19 Vaccine

Russia's Sputnik V COVID-19 Vaccine Is 91% Effective

The Russian Direct Investment Fund (RDIF)

COVID-19 Vaccine

Moderna’s COVID-19 Vaccine Candidate Meets its Primary Efficacy Endpoint in the First Interim Analysis of the Phase 3 COVE Study

Moderna

Cancer Vaccine

Moderna Announces Clinical Updates on Personalized Cancer Vaccine Program

Moderna

Fast Track

Novavax COVID-19 Vaccine Granted Fast Track Designation by U.S. FDA

Novavax

COVID-19 Vaccine

Sanofi and GSK to Support COVAX with 200 Million Doses of COVID-19 Vaccine

GSK